Recombinant Activated Factor VII, as a Remedy for Intractable Coagulopathy Following Massive Transfusion in a Case of Giant Cranial Neurofibroma
Author(s):
Abstract:
Introduction
Neurosurgical interventions have been associated with troublesome bleeding during and after the procedures. There are cases of intractable coagulopathy with life threatening bleeding. In this study, we reported a patient with neurofibromatosis type 1, and huge cranial neurofibroma, associated with massive bleeding after excision.Case Presentation
A 22 year-old man was referred to this center with facial deformity due to a large craniofacial neurofibroma. He underwent craniotomy and tumor resection, but intraoperative blood loss was massive, and epidural hematomata developed at the operative site due to coagulopathy. The drains still were draining fresh blood and the patient was severely anemic. After consultation with a hematologist, rFVIIa was administered intravenously to successfully control the bleeding.Conclusions
While using recombinant rFVIIa is life-saving, it should not be a substitute for life saving urgent surgeries and should be cautiously used as a last resort in conjunction with conventional medico-surgical care.Language:
English
Published:
Archives of Neuroscience, Volume:2 Issue: 1, Jan 2014
Page:
3
magiran.com/p1295685
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یکساله به مبلغ 1,390,000ريال میتوانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.
In order to view content subscription is required
Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!